The roots, leaves and stems of Christia vespertilionis were separately and successively extracted with methanol and aqueous-methanol (1:4, v/v) and were evaluated in vitro for their antiplasmodial potential against Plasmodium falciparum NF-54. The aqueous-methanolic stem (AS) extract was the most active (IC 50 7.5 µg/mL) followed by the methanolic leaf (ML) extract (IC 50 32.0 µg/mL). The in vivo antimalarial activity of the combined plant extract of C. vespertilionis was also assessed in P. berghei infected mice, which showed 87.8% suppression of parasitaemia as compared with complete suppression by chloroquine on day 8. Finally, detailed chemical investigation of C. vespertilionis resulted in the isolation and characterization of fifteen compounds (1-15), of which two (1 and 4) are being reported for the first time from nature. The novel compound 1 possesses potent antiplasmodial activity (IC 50 = 9.0 µg/mL).
Malaria is one of the most common infectious diseases in the tropical and subtropical regions of the world [1] . However, as a result of intensive efforts to control malaria, since 2000, mortality rates have fallen by more than 25% globally and by 33% in the African region [2] , but the increased resistance of Plasmodium falciparum to common antimalarial drugs, including chloroquine [3, 4] and artemisinin [5] , have created an urgent need for the search of new antimalarial agents.
Christia vespertilionis (L.) Bakh. f. (syn. Laurea vespertilionis, Hedysarum vespertilionis; Family-Fabaceae) is an ornamental plant, commonly known as 'Mariposa' or 'Red butterfly wing' because of the similarity of its leaves to a butterfly in color and shape [6] . C. vespertilionis is used to treat tuberculosis, bronchitis and inflamed tonsils, colds, muscle weakness and poor blood circulation [6] . The application of crushed leaves of C. vespertilionis on affected body parts provides a cure for scabies [7] . As a part of our ongoing drug discovery programme for antimalarial agents from medicinal plants [8, 9] , a recent report on the antiplasmodial activity of C. vespertilionis extract [10] prompted us to carry out a detailed bioassay guided investigation for the isolation and characterization of antimalarial agents. In the present study, the in vitro antiplasmodial potential of the methanolic and aqueous-methanolic extracts of roots, leaves and stems of C. vespertilionis were evaluated against P. falciparum NF-54 strain and the results are presented in Table 1 . Out of all the extracts, the aqueous-methanolic (1:4, v/v) extract of the stem was the most potent (IC 50 = 7.5 µg/mL), followed by the methanolic extract of the leaf (IC 50 = 32.0 µg/mL), while the others showed only moderate antiplasmodial activities (IC 50 60.5-78.5 µg/mL) against P. falciparum NF-54.
Although the in vitro antiplasmodial activity of the various extracts was different, their TLC profiles were more or less the same, hence the extracts were combined. In order to evaluate the in vivo antimalarial activity of the combined extract of C. vespertilionis, the rodent model of P. berghei infected Swiss inbred mice was used. The combined extract exhibited 87.8% suppression of parasitaemia on day 8 as compared with absolute suppression by chloroquine.
In order to isolate the active compounds from C. vespertilionis, the combined extract was dissolved in distilled water and successively partitioned with n-hexane, ethyl acetate, and n-BuOH (saturated with water), which afforded n-hexane, ethyl acetate, and n-BuOH fractions, respectively. Repeated chromatographic separation of the n-hexane fraction afforded two novel compounds (1 and 4), along with eight known ones (2-3 and 5-10). The ethyl acetate fraction afforded four compounds (11) (12) (13) (14) , while the n-butanol fraction afforded one (15) , along with a complex mixture of many compounds.
The ESI-MS of compound 1 exhibited a peak at m/z 189 [M+H] + in positive mode suggesting the molecular formula C 14 H 20 (188), which was further supported by a HRMS peak at m/z 188.1573 ([M] + , calcd. 188.1565). The IR (CCl 4 ) spectrum exhibited absorption bands at 1377 (gem-dimethyl) and 1654 (olefinic). The 1 H NMR spectrum showed six types of proton signals at δ H 1.39 (3H, br), 1.60 (6H, s), 1.68 (1H, m), 2.01(2H, m), 2.05 (6H m) and 5.12 (2H, brs). The 13 C NMR spectrum showed twelve signals: two methyls (δ C 16.0 and 17.7); four for methylenes (δ C 26.7, 26.8, 28.3 and 39.7); two olefinic methines (δ C 124.3 and 124.4); and three quaternary olefinic carbons (δ C 131.2, 135.1 and 134.9). The downfield signal at δ H 5.12 in the 1 H NMR spectrum was characteristic of endocyclic olefinic protons, which, in the HSQC spectrum, showed correlation with δ C 124.3 and 124.4. The adjacent nature of the two cis olefinic protons (δ H 5.12) was further confirmed by their 1 H-1 H COSY correlations. The protons at δ H 1.60 (6H, s) showed HSQC correlation with the methyl carbon at δ C 17.7 indicating overlapping of carbon signals. The five degrees of unsaturation in the molecule and the presence of only two cis olefinic protons suggested that the molecule had a bicyclic sesquiterpene skeleton [11, 12] . The methyl proton signal at δ H 1.60 showed HMBC correlations with δ C 131.2 (C-11) and 134.9 (C-7). Another methyl proton signal at δ H 1.39 was assigned to the carbon at δ C 16.0, which showed HMBC correlations with δ C 25.7 (C-1) and 135.1 (C-10). On the basis of this, the value δ H 1.39 (δ C 16.0, C-14) was given to the methyl group attached at C-1. Further, unambiguous assignment of the methyl carbon at C-14 was achieved by HMBC correlations of δ H 2.01 (H-2, δ C 39.7), which correlated with δ C 16.0 (C-14, δ H 1.39), 124.3 (C-4) and 124.4 (C-3). The proton at δ H 1.60 (H-12, 13) showed HMBC correlations with δ C 131.2 (C-11) and 134.9 (C-7). The downfield protons at δ H 2.05 showed HSQC correlation with methylene carbons at δ C 26.7 (C-9), 26.8 (C-8) and 28.3 (C-6), and a HMBC correlation with δ C 26.8, 124.3, 135.1 and 134.9. The methine proton at δ H 1.68 (δ C 25.7, C-1) showed strong HMBC correlations with δ C 124.4 (C-3) and 131.2 (C-5). The olefinic proton at δ H 5.12 showed HMBC correlations with δ C 25.7 (C-1) and 39.7 (C-2). Based on the forgoing spectral evidence, compound 1 was characterized as 7isopropylidene-1-methyl-1, 2, 6, 7, 8, 9-hexahydronaphthalene, and was named christene. . Based on the above spectroscopic evidence, the structure of 4 was deduced as 2'-hydroxydecanylpentadec-5, 8, 10, 12-tetraenoate; named as christanoate. The 1 H and 13 C NMR assignments of compound 4 were in agreement with similar types of compounds reported in literature [14, 15] .
HMBC COSY
Finally, the product obtained after acid hydrolysis of compound 4 was subjected to GC-MS analysis, which showed the presence of two intense mass peaks at m/z 175 [M+H] + (calculated for C 10 A total of thirteen known compounds were identified viz, three pentacyclic triterpenes: D:C-friedoolean-8-en-29α-ol (7) , ursolic acid methyl ester (8), oleanolic acid methyl ester (9) and erythrodiol (10); three isoflavonoids: 2'-hydroxy genestin (11) , orobol (12) and 2,3-dihydro-2'-hydroxy-genestin (13); two flavonoid glycosides: quercetin-3-O-glucoside (14) and catechin-3-O-β-Dglucopyranoside (15); three steroids: stigmasterol (2), β-sitosterol acetate (5) and β-sitosterol (6); and a monoterpene: geraniol (3). All the compounds were identified by comparison of physical and spectroscopic data (UV, IR, 1 H-, 13 C-NMR, MS) with those of corresponding authentic samples and values reported in the literature. The isolated compounds 2, 3, 5, 6, 8, 9 and 14 were also identified by co-TLC with an authentic sample.
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The novel compounds 1 and 4 (Figure 4 ) along with compound 13 were evaluated for their in vitro antiplasmodial potential, which showed that only compound 1 was significantly active (IC 50 9.0 µg/mL). The other isolated compounds were not evaluated, either due to paucity or their known antiplasmodial activity [16, 17] . Except compound 1, none of the tested compounds showed potential antiplasmodial activity; hence, it may be concluded that the antiplasmodial potential of the various extracts of C. vespertilionis is due to additive effects of all its antimalarial constituents. Finally, it may be concluded that extracts of C. vespertilionis possess varying degree of antiplasmodial activity, and may find potential use in phytopharmaceuticals. Nevertheless, further investigations to ascertain in vivo toxicity of the plant and dose optimizations are required to provide an effective and low cost malaria treatment for the common and poor masses of the entire world. 
Experimental

Extraction and isolation:
The shade dried and finely milled samples of C. vespertilionis {root (218 g), leaf (120 g) and stem (480 g)} were separately extracted successively with methanol and aqueous-methanol (1:4, v/v) overnight (1-4 L x 3 each), and the combined extracts were separately evaporated under reduced pressure to yield methanolic extracts from roots (MR, 14.63 g), leaf (ML, 18.77 g), and stem (MS, 29.02 g), and aqueous-methanolic extracts from roots (AR, 5.40 g), leaf (AL, 6.06 g), and stem (AS, 8.51 g). A 500 mg sample of each extract was separately kept under -20 0 C for antimalarial activity evaluation, and the rest were combined because of the presence of common major constituents as evidenced by TLC. The combined plant extract (80 g) was successively partitioned to afford n-hexane (11.35 g), ethyl acetate (4.0 g) and n-BuOH (9.8 g) soluble fractions.
The n-hexane fraction (10.35 g) was subjected to repeated chromatographic separation using vacuum liquid chromatography (VLC), CC and preparative TLC, which afforded compounds 1 (23.5 mg), 2 (125.0 mg), 3 (30 mg), 4 (127 mg), 5 (27.5 mg), 6 (230 mg), 7 (9.5 mg), 8 (15.7 mg), 9 (13.5 mg) and 10 (45.6 mg). The repeated chromatographic separation of the ethyl acetate fraction (3.2 g) using flash chromatography (FC) and preparative TLC afforded compounds 11 (18 mg), 12 (14 mg), 13 (15 mg) and 14 (39 mg). The n-butanol fraction (8.8 g) was chromatographed by FC and the fractions eluted with chloroform-methanol (8.8:1.2) were pooled and dried; the dried mass (180 mg) was dissolved in a minimum amount of methanol and precipitated by slow addition of acetone. Preparative TLC separation of the acetone soluble portion (liquor) afforded compound 15 (25 mg). -1-methyl-1,2,6,7,8,9- 13 
7-Isopropylidene
Biological assays:
The in vitro antiplasmodial assays were performed against P. falciparum (NF-54 strain) cultured in human type O-positive red blood cells according to an earlier described method, and the IC 50 values were calculated from dose response curves prepared from percentage inhibition values versus concentration using Graph Pad Prism (Version 4.0) [18, 19] . Plasmodium berghei K173 (sensitive to chloroquine at 10 mg/Kg) was used to assess the in vivo intrinsic antimalarial activity. The strain was procured from the Central Drug Research Institute, Lucknow, India and the antimalarial study was made following the procedures reported in our earlier paper [20] . The details have been provided in the supplementary data. 
